Reclast is an annual osteoporosis treatment. It's a bisphosphonate like Fosamax,^® Actonel,^® and Boniva,^® but it's not a pill that you have to take every week or month. Reclast is an infusion and is the only FDA-approved treatment for postmenopausal osteoporosis that works in just one dose a year.

Unlike pills, Reclast bypasses your digestive system so it's not associated with stomach irritation. Because Reclast bypasses your stomach, you won't have to wait to eat, or remain upright for a half hour or more. And since Reclast is an annual osteoporosis treatment you have just one treatment, once a year. Then you can get back to the things you enjoy, on your schedule.

Reclast is given by IV so it goes through your bloodstream to your bones where the majority of the medicine then binds to your bones. The remaining Reclast medication that's not bound to the bones leaves your body within days of treatment.

Our bones normally go through a continual renewal process. Old bone tissue breaks down and new tissue is formed to replace it. With osteoporosis, old bone breaks down faster than new bone is created to replace it.

Reclast slows the breakdown of old bone tissue. This gives new bone a chance to catch up and fill in the areas of bone loss. Reclast has a proven safety profile. A clinical trial with over 7700 patients over three years has proven the effectiveness of Reclast. And since it became available in 2007, to date, over one million infusions have been delivered worldwide.

Fosamax is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Actonel is a registered trademark of Warner Chilcott Company, LLC. Boniva is a registered trademark of Roche Therapeutics Inc.